- Home
- WKHS vs SNGX Comparison
WKHS vs SNGX Comparison
Compare WKHS & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKHS
- SNGX
- Stock Information
- Founded
- WKHS 2007
- SNGX 1987
- Country
- WKHS United States
- SNGX United States
- Employees
- WKHS N/A
- SNGX N/A
- Industry
- WKHS Auto Manufacturing
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- WKHS Consumer Discretionary
- SNGX Health Care
- Exchange
- WKHS Nasdaq
- SNGX Nasdaq
- Market Cap
- WKHS 6.0M
- SNGX 6.5M
- IPO Year
- WKHS N/A
- SNGX 1987
- Fundamental
- Price
- WKHS $1.14
- SNGX $1.37
- Analyst Decision
- WKHS Hold
- SNGX
- Analyst Count
- WKHS 1
- SNGX 0
- Target Price
- WKHS $15.62
- SNGX N/A
- AVG Volume (30 Days)
- WKHS 510.7K
- SNGX 147.3K
- Earning Date
- WKHS 08-19-2025
- SNGX 08-08-2025
- Dividend Yield
- WKHS N/A
- SNGX N/A
- EPS Growth
- WKHS N/A
- SNGX N/A
- EPS
- WKHS N/A
- SNGX N/A
- Revenue
- WKHS $5,917,985.00
- SNGX $2,342.00
- Revenue This Year
- WKHS $54.16
- SNGX N/A
- Revenue Next Year
- WKHS $85.00
- SNGX N/A
- P/E Ratio
- WKHS N/A
- SNGX N/A
- Revenue Growth
- WKHS N/A
- SNGX N/A
- 52 Week Low
- WKHS $0.81
- SNGX $1.31
- 52 Week High
- WKHS $28.13
- SNGX $14.83
- Technical
- Relative Strength Index (RSI)
- WKHS 58.99
- SNGX 23.71
- Support Level
- WKHS $0.93
- SNGX $1.31
- Resistance Level
- WKHS $1.20
- SNGX $1.95
- Average True Range (ATR)
- WKHS 0.09
- SNGX 0.07
- MACD
- WKHS 0.03
- SNGX -0.05
- Stochastic Oscillator
- WKHS 79.08
- SNGX 9.56
About WKHS Workhorse Group Inc.
Workhorse Group Inc is a technology company with a vision to pioneer the transition to zero-emission commercial vehicles. Its focus is to provide sustainable and cost-effective solutions to the commercial transportation sector. It designs and manufactures all-electric delivery trucks and drone systems, including the technology that optimizes the way these vehicles operate. It's focused on a core competency of bringing electric delivery vehicle platforms to serve the last-mile delivery market. Its products are marketed under the Workhorse brand.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).